يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Kyn/Trp ratio"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Molfino, Alessio, Imbimbo, Giovanni, Amabile, Maria Ida, Ammann, Thoma, Lionetto, Luana, Salerno, Gerardo, Simmaco, Maurizio, Chiappini, Maria Grazia, Muscaritoli, Maurizio

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36839234; info:eu-repo/semantics/altIdentifier/wos/WOS:000941703800001; volume:15; issue:4; numberofpages:11; journal:NUTRIENTS; https://hdl.handle.net/11573/1688751Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85148884292

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المساهمون: Mandarano, Martina, Orecchini, Elena, Bellezza, Guido, Vannucci, Jacopo, Ludovini, Vienna, Baglivo, Sara, Tofanetti, Francesca Romana, Chiari, Rita, Loreti, Elisabetta, Puma, Francesco, Sidoni, Angelo, Belladonna, Maria Laura

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33922388; info:eu-repo/semantics/altIdentifier/wos/WOS:000650354800001; volume:22; issue:9; numberofpages:14; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; https://hdl.handle.net/11573/1660546Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104497944

  4. 4
    دورية أكاديمية
  5. 5

    المصدر: International Journal of Molecular Sciences
    Volume 22
    Issue 9
    International Journal of Molecular Sciences, Vol 22, Iss 4403, p 4403 (2021)

    وصف الملف: application/pdf

  6. 6
    دورية أكاديمية
  7. 7

    المساهمون: Obstetrics and gynaecology, CCA - Innovative therapy, Cancer Center Amsterdam, Obstetrics and Gynaecology, Other departments, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Lifestyle Medicine (LM), Targeted Gynaecologic Oncology (TARGON), Translational Immunology Groningen (TRIGR)

    المصدر: OncoImmunology, 4(2):e981457. Landes Bioscience
    Oncoimmunology, 4(2). Landes Bioscience
    OncoImmunology, 4(2):981457. Taylor & Francis Group
    Ferns, D M, Kema, I P, Buist, M R, Nijman, H W, Kenter, G G & Jordanova, E S 2015, ' Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival ', OncoImmunology, vol. 4, no. 2, e981457 . https://doi.org/10.4161/2162402X.2014.981457Test